Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0006432
UniProt IDQ9UNP9
Primary gene name(s)PPIE
Synonym gene name(s)CYP33
Protein namePeptidyl-prolyl cis-trans isomerase E
Protein functionPPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. Combines RNA-binding and PPIase activities. May be involved in muscle- and brain-specific processes. May be involved in pre-mRNA splicing.
Subcellular locationNucleus.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q9UNP9
Gene Ontology
(Biological Process)
Complete annatation
mRNA splicing, via spliceosome [GO:0000398];
positive regulation of viral genome replication [GO:0045070];
protein folding [GO:0006457];
regulation of transcription, DNA-templated [GO:0006355];
transcription-coupled nucleotide-excision repair [GO:0006283]
Gene Ontology
(Molecular Function)
Complete annatation
cyclosporin A binding [GO:0016018];
nucleotide binding [GO:0000166];
peptidyl-prolyl cis-trans isomerase activity [GO:0003755];
poly(A RNA binding [GO:0044822];
RNA binding [GO:0003723]
Gene Ontology
(Cellular Component)
Complete annatation
catalytic step 2 spliceosome [GO:0071013];
nucleoplasm [GO:0005654];
nucleus [GO:0005634]
Protein-protein interaction115714
Phylogenetic treeQ9UNP9
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
      unknown
Brass et al., Science, 2008
      unknown
Smith et al., J. Immunol, 2010
      unknown
Interferon-stimulated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model


DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.2862719991724260.3829561217027450.504587139172523
AZA vs. DISU-0.2108541908351210.4059174954189640.906488937177106
AZA vs. IL7-0.008319787368458060.965663269371710.999311006273513
AZA vs. SAHA-0.5736301882486290.01975544655489490.153264848877244
DISU vs. CD3-0.5092931340221190.1613541774201510.270520839776595
DISU vs. IL70.1929370282710160.44494739249510.793108832977933
DISU vs. SAHA-0.3608550994577810.2179188149791990.593033387891616
DMSO vs. AZA-0.05201222918993130.758027489085171
DMSO vs. CD3-0.349680759139940.275413340490380.383927267001719
DMSO vs. DISU0.1570085024766630.5210679536734880.914921957877669
DMSO vs. IL70.05087578370505990.7784461013882570.95414107268595
DMSO vs. SAHA-0.5273041194014230.02656332520024410.170500798165621
HIV vs. Mock in Activation-0.1641720049156240.7921247327541470.999983755607037
HIV vs. Mock in Latency0.08922771672914120.5914005523343640.999834320637052
IL7 vs. CD3-0.2879234707197370.3709322203272120.508093543892409
SAHA vs. CD3-0.8834044977262050.01311736602529790.0322057194527923
SAHA vs. IL7-0.5677187694968480.02074166268913140.10301806371531
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) unknown
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.25645 0.150351
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.048 0.927 1.002 0.916 0.932
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
1ZMF X-ray 1.8Å A=137-301.
2CQB NMR - A=1-89.
2KU7 NMR - A=2-82.
2KYX NMR - A=3-83.
2R99 X-ray 1.6Å A=131-301.
3LPY X-ray 2.0Å A/B=5-82.
3MDF X-ray 1.8Å A/B=1-83.
3UCH X-ray 2.5Å A=129-301.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
capsid interacts with 25505242

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa03040 Spliceosome - Homo sapiens (human)
Menu